Literature DB >> 27083563

Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis.

Daichi Yokoi1, Naoki Atsuta1, Hazuki Watanabe2, Ryoichi Nakamura1, Akihiro Hirakawa3, Mizuki Ito1, Hirohisa Watanabe1, Masahisa Katsuno1, Yuishin Izumi4, Mitsuya Morita5, Akira Taniguchi6, Masaya Oda7, Koji Abe8, Kouichi Mizoguchi9, Osamu Kano10, Satoshi Kuwabara11, Ryuji Kaji4, Gen Sobue12.   

Abstract

The clinical courses of sporadic amyotrophic lateral sclerosis (ALS) show extensive variability. Our objective was to elucidate how age of onset influences the progression of regional symptoms and functional losses in sporadic ALS. We included 648 patients with sporadic ALS from a multicenter prospective ALS cohort. We investigated the distribution of initial symptoms and analyzed the time from onset to events affecting activities of daily living (ADL) as well as the longitudinal changes in each regional functional rating score among four groups with different ages of onset. The frequencies of dysarthria and dysphagia as initial symptoms were higher in the older age groups, whereas weakness of upper limbs was the most common initial symptom in the youngest age group. The survival times and the times from onset to loss of speech and swallowing were significantly shorter in the older age group (p < 0.001), although the times from onset to loss of upper limb function were not significantly different among the age groups. According to joint modeling analysis, the bulbar score declined faster in the older age groups (<50 vs. 60-69 years: p = 0.029, <50 vs. ≥70 years: p < 0.001), whereas there was no significant correlation between the age of onset and decline in the upper limb score. Our results showed that age of onset had a significant influence on survival time and the progression of bulbar symptoms, but had no influence on upper limb function in sporadic ALS.

Entities:  

Keywords:  Age of onset; Bulbar upper limb function; Sporadic ALS

Mesh:

Year:  2016        PMID: 27083563     DOI: 10.1007/s00415-016-8109-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Progression in ALS is not linear but is curvilinear.

Authors:  Paul H Gordon; Bin Cheng; Francois Salachas; Pierre-Francois Pradat; Gaelle Bruneteau; Philippe Corcia; Lucette Lacomblez; Vincent Meininger
Journal:  J Neurol       Date:  2010-06-08       Impact factor: 4.849

3.  The numbers of limb motor neurons in the human lumbosacral cord throughout life.

Authors:  B E Tomlinson; D Irving
Journal:  J Neurol Sci       Date:  1977-11       Impact factor: 3.181

Review 4.  Prognostic factors for the course of functional status of patients with ALS: a systematic review.

Authors:  Huub Creemers; Hepke Grupstra; Frans Nollet; Leonard H van den Berg; Anita Beelen
Journal:  J Neurol       Date:  2014-11-11       Impact factor: 4.849

5.  Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy.

Authors:  S Zoccolella; E Beghi; G Palagano; A Fraddosio; V Samarelli; P Lamberti; V Lepore; L Serlenga; G Logroscino
Journal:  Eur J Neurol       Date:  2006-07       Impact factor: 6.089

6.  Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.

Authors:  Hazuki Watanabe; Naoki Atsuta; Ryoichi Nakamura; Akihiro Hirakawa; Hirohisa Watanabe; Mizuki Ito; Jo Senda; Masahisa Katsuno; Yuishin Izumi; Mitsuya Morita; Hiroyuki Tomiyama; Akira Taniguchi; Ikuko Aiba; Koji Abe; Kouichi Mizoguchi; Masaya Oda; Osamu Kano; Koichi Okamoto; Satoshi Kuwabara; Kazuko Hasegawa; Takashi Imai; Masashi Aoki; Shoji Tsuji; Imaharu Nakano; Ryuji Kaji; Gen Sobue
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-12-30       Impact factor: 4.092

7.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Authors:  Kim Traxinger; Crystal Kelly; Brent A Johnson; Robert H Lyles; Jonathan D Glass
Journal:  Neurol Clin Pract       Date:  2013-08

Review 8.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

9.  Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.

Authors:  Petra Kaufmann; Gilbero Levy; Jacquelina Montes; Richard Buchsbaum; Alexandra I Barsdorf; Vanessa Battista; Rachel Arbing; Paul H Gordon; Hiroshi Mitsumoto; Bruce Levin; John L P Thompson
Journal:  Amyotroph Lateral Scler       Date:  2007-02

10.  Co-occurrence of TDP-43 mislocalization with reduced activity of an RNA editing enzyme, ADAR2, in aged mouse motor neurons.

Authors:  Takuto Hideyama; Sayaka Teramoto; Kosuke Hachiga; Takenari Yamashita; Shin Kwak
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more
  4 in total

1.  Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort.

Authors:  Francesca Trojsi; Mattia Siciliano; Cinzia Femiano; Gabriella Santangelo; Christian Lunetta; Andrea Calvo; Cristina Moglia; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialò; Gianni Sorarù; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Valeria Ada Sansone; Adriano Chiò; Gabriele Mora; Barbara Poletti; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Antonio Fasano; Maria Rosaria Monsurrò; Gioacchino Tedeschi; Jessica Mandrioli
Journal:  J Neurol       Date:  2017-09-15       Impact factor: 4.849

2.  The influence of initial symptoms on phenotypes in spinocerebellar ataxia type 3.

Authors:  Hao-Ling Xu; Qiu-Ni Su; Xian-Jin Shang; Arif Sikandar; Min-Ting Lin; Ning Wang; Hong Lin; Shi-Rui Gan
Journal:  Mol Genet Genomic Med       Date:  2019-05-23       Impact factor: 2.183

3.  Milano-Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.

Authors:  Ruojie He; Minying Zheng; Ling Lian; Xiaoli Yao
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

4.  The Relationship between Selected Demographic Factors and Speech Organ Dysfunction in Sporadic ALS Patients.

Authors:  Wioletta Pawlukowska; Bartłomiej Baumert; Monika Gołąb-Janowska; Agnieszka Meller; Karolina Machowska-Sempruch; Agnieszka Wełnicka; Edyta Paczkowska; Iwona Rotter; Bogusław Machaliński; Przemysław Nowacki
Journal:  Medicina (Kaunas)       Date:  2020-08-05       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.